发明名称 Containers for compositions comprising meloxicam
摘要 A plastic container containing a pharmaceutical composition comprising benzoic acid or a derivative or a pharmaceutically acceptable salt thereof and a COX-inhibitor of the oxicam-type or a pharmaceutical acceptable salt thereof, wherein the container material selected from one or more members of the group consisting of a homopolymer of polypropylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET), and optionally one or more non-polymeric components.
申请公布号 US9186296(B2) 申请公布日期 2015.11.17
申请号 US201313799901 申请日期 2013.03.13
申请人 Boehringer Ingelheim Vetmedica GmbH 发明人 Folger Martin A.;Crowley Samuel C.;Wilson Amy J.
分类号 B65D81/00;B65D81/02;B65D83/40;A61J1/00;A61J1/05;A61J1/14;A61K47/12;A61J1/20 主分类号 B65D81/00
代理机构 代理人 Morris Michael P.;Morrison Joyce L.
主权项 1. A pharmaceutically acceptable container containing a pharmaceutical composition including sodium benzoate, the container being formed of a container material selected from one or more members of the group constisting of a homopolymer of polypropylene (PP), a copolymer of polypropylene (PP), a homopolymer of polyethylene terephthalate (PET) and a copolymer of polyethylene terephthalate (PET); wherein the container material does not include high-density polyethylene (HDPE), low-densisty polyethylene (LDPE), or polycarbonate (PC); and a loss in concentration (mg/mL) of sodium benzoate in said pharmaceutical composition due to adsorption onto said container when stored for a period of 6 months at 25° C. and a relative humidity of 60% is no more than 5%.
地址 Ingelheim am Rhein DE